Testing new TB screening and diagnostic tests
Part of Infections clinical trials.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an outpatient adult or teen age 12+ (not currently hospitalized)
- Have symptoms like cough lasting 2 or more weeks OR a TB risk factor
- If you have HIV, close contact, or past mining work, you must screen positive using a WHO-recommended symptom/chest X-ray check
- Be able to return for follow-up visits and live within 20 km of the study site
- If you already had TB treatment in the last 12 months, you can’t join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new tools that can check for tuberculosis (TB) more quickly at or near where care happens. It includes people with cough or TB risk factors, and also the health workers who perform TB testing, to see how well the tests work and how easy they are to use.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study is testing new ways to quickly diagnose TB in children under 15. It aims to find better tests that can be used at clinics, especially for kids who may not have obvious symptoms.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This study aims to better understand how the immune system responds to tuberculosis (TB) and improve tools for diagnosing and managing the disease. It may help people with active TB, their close contacts, people with certain other lung diseases, or healthy individuals.
This study is testing a new way to diagnose tuberculosis (TB) without needing sputum (phlegm) samples. It aims to find a simpler, faster method for people with possible TB or other lung infections.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.